These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 14730790)

  • 1. The uncertain future of continuing medical education: commercialism and shifts in funding.
    Van Harrison R
    J Contin Educ Health Prof; 2003; 23(4):198-209. PubMed ID: 14730790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commercial support of continuing medical education in the United States: the politics of doubt, the value of studies.
    Mazmanian PE
    J Contin Educ Health Prof; 2009; 29(2):81-3. PubMed ID: 19530200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commercial Interests in Continuing Medical Education: Where Do Electronic Health Record Vendors Fit?
    Rubinstein PF; Middleton B; Goodman KW; Lehmann CU
    Acad Med; 2020 Nov; 95(11):1674-1678. PubMed ID: 32079950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinician attitudes about commercial support of continuing medical education: results of a detailed survey.
    Tabas JA; Boscardin C; Jacobsen DM; Steinman MA; Volberding PA; Baron RB
    Arch Intern Med; 2011 May; 171(9):840-6. PubMed ID: 21555662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Conflict of interest in continuing medical education - Studies on certified CME courses].
    Lenzen LM; Weidringer JW; Ollenschläger G
    Z Evid Fortbild Qual Gesundhwes; 2016; 110-111():60-8. PubMed ID: 26875037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining the value of commercially supported CME.
    Miller LA
    J Contin Educ Health Prof; 2009; 29(1):68-70. PubMed ID: 19288557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical industry financial support for medical education: benefit, or undue influence?
    Brody H
    J Law Med Ethics; 2009; 37(3):451-60, 396. PubMed ID: 19723256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commercial support and the quandary of continuing medical education.
    Schaffer MH
    J Contin Educ Health Prof; 2000; 20(2):120-6. PubMed ID: 11232220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between physicians and the pharmaceutical industry: what does the literature say?
    Lexchin J
    CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Continuing Medical Education at U.S. Medical Schools and Other Accredited Organizations: A 20-Year Analysis.
    Rayburn WF; Regnier K; McMahon GT
    Acad Med; 2020 Apr; 95(4):623-628. PubMed ID: 31626001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A view from industry: the foundations of future commercial support and a call for action.
    Saxton M
    J Contin Educ Health Prof; 2009; 29(1):71-5. PubMed ID: 19288558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low rates of reporting commercial bias by physicians following online continuing medical education activities.
    Ellison JA; Hennekens CH; Wang J; Lundberg GD; Sulkes D
    Am J Med; 2009 Sep; 122(9):875-8. PubMed ID: 19699386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A risk stratification tool to assess commercial influences on continuing medical education.
    Barnes BE; Cole JG; King CT; Zukowski R; Allgier-Baker T; Rubio DM; Thorndyke LE
    J Contin Educ Health Prof; 2007; 27(4):234-40. PubMed ID: 18085603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commercial support and continuing medical education.
    Steinbrook R
    N Engl J Med; 2005 Feb; 352(6):534-5. PubMed ID: 15703417
    [No Abstract]   [Full Text] [Related]  

  • 15. Industry support of CME--are we at the tipping point?
    Steinman MA; Landefeld CS; Baron RB
    N Engl J Med; 2012 Mar; 366(12):1069-71. PubMed ID: 22435367
    [No Abstract]   [Full Text] [Related]  

  • 16. Accreditation for learning and change: quality and improvement as the outcome.
    Regnier K; Kopelow M; Lane D; Alden E
    J Contin Educ Health Prof; 2005; 25(3):174-82. PubMed ID: 16173052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Medical Profession, Industry, and Continuing Medical Education: Finding the Balance That's Right for Patients.
    Kearney P; Simoons M; Ryden L; Kirchhof P; Pries A; O'Morain C; Bax JJ
    Am J Med; 2019 Aug; 132(8):921-925. PubMed ID: 30853472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CME, physicians, and Pavlov: can we change what happens when industry rings the bell?
    Lichter PR
    Trans Am Ophthalmol Soc; 2008; 106():39-43; discussion 44-5. PubMed ID: 19277219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug advertising, continuing medical education, and physician prescribing: a historical review and reform proposal.
    Rodwin MA
    J Law Med Ethics; 2010; 38(4):807-15. PubMed ID: 21105944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Academic" CME and the social contract.
    Davis D; Parboosingh J
    Acad Med; 1993 May; 68(5):329-32. PubMed ID: 8484835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.